2 results
Approved WMORecruiting
- To evaluate the treatment efficiency by time to progression according to RECIST 1.1
Approved WMOCompleted
The study aims to limit the use of anthracyclines and to reduce the dose of ATRA. Another aim is to stratify treatment by risk group: standard risk - WBC <10 x 109/l : high risk - WBC >=10 x 109/l. Furthermore this study aims to…